Clinical Trial Update: Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating elemene for refractory glioblastoma is reported, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Elemene (elemene)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Refractory Glioblastoma | Phase 2 | Status: UNKNOWN